GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 2, 2000, Pages 185-191

  Olshan, Andrew F ^a,b   Weissler, Mark C ^b   Watson, Mary A ^c   Bell, Douglas A ^c  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CARCINOGEN; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; ISOLEUCINE; VALINE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK CANCER; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO;

ACETYLTRANSFERASES; ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 0033998142     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Smith, G., Stanley, L. A., Sim, E., Strange, R. C., and Wolf, C. R. Metabolic polymorphisms and cancer susceptibility. Cancer Surv., 25: 27-65, 1995.
2. Rebbeck, T. R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomark. Prev., 6: 733-743, 1997.
3. Greenland, S. Dose-response and trend analysis: alternatives to category-indicator regression. Epidemiology, 6: 356-365, 1995.
4. Chen, H., Sandler, D., Taylor, J. A., Shore, D. L., Liu, E., Bloomfield, C., and Bell, D. A. Increased risk for myelodysplastic syndromes among those with glutathione S-transferase θ 1 gene defect. Lancet, 347: 295-297, 1996.
5. Watson, M. A., Stewart, R. L., Smith, G. B. J., Massey, T. J., and Bell, D. A. Human glutathione S-transferase P1 polymorphisms. Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis (Lond.), 19: 275-280, 1998.
6. Bell, D. A., Stephens, E. A., Castranio, T., Umbach, D. M., Watson, M. A., Deakin, M., Elder, J., Hendrickse, C., Duncan, H., and Strange, R. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55: 3537-3542, 1995.
7. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research. I. The Analysis of Case-Control Studies. IARC Scientific Publication No. 35. Lyon, France: IARC, 1980.
8. Rothman, K. J., and Greenland, S. Modern Epidemiology, Ed. 2, pp. 340-341. Philadelphia: Lippincott-Raven, 1998.
9. Hosmer, D. W., and Lemeshow, S. Confidence interval estimation of interaction. Epidemiology, 3: 452-456, 1992.
10. Bell, D. A., Taylor, J. A., Paulson, D., Robertson, D., Mohler, J., and Lucier, G. W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione transferase mu is associated with increased susceptibility to bladder cancer. J. Natl. Cancer Inst., 85: 1159-1164, 1993.
11. Millikan, R., Pittman, G., Newman, B., Tse, J., Rockhill, B., Savitz, D., Moorman, P., and Bell, D. A. Cigarette smoking, N-acetyltransferase 1 and 2 and breas: cancer risk. Cancer Epidemiol. Biomark. Prev., 7: 371-378, 1998.
12. Nakachi K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphism of the CYP1A1 and glutathione S-transferase genes associated with susceptibility of lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993.
13. Park, J. Y., Muscat, J. E., Ren, Q., Schantz, S. P., Harwick, R. D., Stern, J. C., Pike, V, Richie, J. P., and Lazarus, P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol. Biomark. Prev., 6: 791-797, 1997.
14. Trinza, Z., Clayman, G. L., Spitz, M. R., Briggs, K. L., and Geopfert, H. Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am. J. Surg., 170: 499-501, 1995.
15. Deakin, M., Elder, J., Hendrickse, C., Peckham, D., Baldwin, D., Pantin, C., Wild, N., Leopard, P., Bell, D. A., Jones, P., Duncan, H., Brannigan, K., Alldersea, J., Fryer, A. A., and Strange, R. C. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis (Lond.), 17: 881-884, 1996.
16. Jahnke, V., Matthias, C., Fryer, A., and Strange, R. Glutathione S-transferase and cytochrome P-450 polymorphisms risk factors for squamous cell carcinoma of the larynx. Am. J. Surg., 172: 671-673, 1996.
17. Hung, H-C., Chuang, J., Chien, Y-C., Chern, H-D., Chiang, C-P., Kuo, Y-S., Hildersheim, A., and Chen, C-J. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1: environmental factors and risk of oral cancer. Cancer Epidemiol. Biomark. Prev., 6: 901-905, 1997.
18. Kihara, M., Kihara, M., Kubota, A., Furukawa, M., and Kimura, H. GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett., 112: 257-262, 1997.
19. Coutelle, C., Ward, P. J., Fleury, B., Quattrocchi, P., Chambrin, H., Iron, A., Couzigou, P., and Cassaigne, A. Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum. Genet., 99: 319-325, 1997.
20. Jourenkova, N., Reinikainen, M., Bouchardy, C., Dayer, P., Benhamou, S., and Hirvonen, A. Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking, Cancer Epidemiol. Biomark. Prev., 7: 19-23, 1998.
21. Matthias, C., Brockmuhl, U., Jahnke, V., Harries, L. W., Wolf, C. R., Jones, P. W., Alldersea, J., Worrall, S. F., Hand, P., Fryer, A. A., and Strange, R. C. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/ pharyngeal and laryngeal carcinomas. Pharmacogenetics, 8: 1-6, 1998.
22. Ophuis, M. B. O., van Lieshout, E. M. M., Roelofs, H. M. J., Peters, W. H. M., and Manni, J. J. Glutathione S-transferase M1, and T1, and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer (Phila.), 82: 936-943, 1998.
23. Gonzalez, M. V., Alvarez, V., Pello, M. F., Menedez, M. J., Suarez, C., and Coto, E. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J. Clin. Pathol., 51: 294-298, 1998.
24. Jourenkova-Mironova, N., Voho, A., Bouchardy, C., Wikman, H., Dayer, P., Benhamou, S., and Hirvonen, A. Glutathione S-transferase GSTM1, GSTM3, GSTP1, and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int. J. Cancer, 81: 44-48, 1999.
25. Jourenkova-Mironova, N., Voho, A., Bouchardy, C., Wikman, H., Dayer, P., Benhamou, S., and Hirvonen, A. Glutathione S-transferase GSTM3, and GSTP1 genotypes and larynx cancer risk. Cancer Epidemiol. Biomark. Prev., 8: 185-188, 1999.
26. Cheng, L., Sturgis, E. M., Eicher, S. A., Char, D., Spitz, M. R., and Wei, Q. Glutathione S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int. J. Cancer, 84: 220-224, 1999.
27. Blot, W. J., McLaughlin, J. K., Winn, D. M., Austin, D. F., Greenberg, R. S., Preston-Martin, S., Bernstein, L., Schoenberg, J. B., Stemhagen, A., and Fraumeni, J. F. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res., 48: 3282-3287, 1988.
28. Mulder, T. P. J., Manni, J. J., Roelofs, H. M. J., Peters, W. H. M., and Wiersma, A. Glutathione S-transferases and glutathione in head and neck cancer. Carcinogenesis (Lond.), 16: 619-624, 1995.
29. Vanden Heuvel, J., Clark, G. C., Thompson, C. L., McCoy, Z., Miller, C. R., Lucier, G. W., and Bell, D. A. CYP1A1 mRNA levels as a human exposure biomarker: the use of quantitative polymerase chain reaction to measure CYP1A1 expression in peripheral blood lymphocytes. Carcinogenesis (Lond.), 14: 2003-2006, 1993.
30. Whyatt, R., Garte, S. J., Cosma, G., Bell, D. A., Jedrychowski, W., Wahrendorf, J., Randall, M., Cooper, T. B., Ottman, R., Tang, D., Tsai, W. Y., Dickey, C., Manchester, D. K., Crofts, F., and Perera, F. P. CYP1A1 mRNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol. Biomark. Prev., 4: 147-154, 1994.
31. Degawa, M., Stern, S. J., Martin, M. V., Guengerich, F. P., Fu, P. P., Ilett, K. F., Kaderlik, R. K., and Kadlubar, F. F. Metabolic activation and carcinogen-DNA adducts detection in human larynx. Cancer Res., 54: 4915-4919, 1994.
32. Badawi, A. F., Bell, D. A., Hirvonen, A., and Kadlubar, F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55: 5230-5237, 1995.
33. Hughes, N., Mcqueen, K., Janezic, S., Jewett, M., Castranio, T., Bell, D. A., and Grant, D. M. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective functions using p-aminosalicylate as an in vivo/in vitro probe. Pharmacogenetics, 8: 55-66, 1998.